NANCY MAYEDA-BRESCIA: Open Payments
NPI 1215952015 · MINNEAPOLIS, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,508 in 26 payments from 9 companies in 2025. Trend: 2023 $559 · 2024 $524 · 2025 $1,508
Food & beverage: $1,508
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 4 | $386 |
| Axsome Therapeutics, Inc. | 7 | $340 |
| Janssen Pharmaceuticals, Inc | 3 | $177 |
| ABBVIE INC. | 4 | $172 |
| Neurocrine BioSciences, Inc. | 2 | $147 |
| Lilly USA, LLC | 2 | $121 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $108 |
| Collegium Pharmaceutical, Inc. | 2 | $40 |
| Corium, LLC | 1 | $19 |
Products named: Auvelity, LYBALVI, SPRAVATO, VRAYLAR, INGREZZA, ARISTADA, CAPLYTA, Jornay PM.
Industry payments across MN — which companies pay providers there.
